메뉴 건너뛰기




Volumn 104, Issue 1, 2009, Pages 257-258

Acute hepatitis in a patient with cirrhosis and hepatocellular carcinoma treated with sorafenib

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CYTOCHROME P450 3A4; GLUCURONOSYLTRANSFERASE 1A9; PROTHROMBIN; SORAFENIB; ANTINEOPLASTIC AGENT; BENZENESULFONIC ACID DERIVATIVE; PROTEIN KINASE INHIBITOR; PYRIDINE DERIVATIVE;

EID: 60749098916     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2008.41     Document Type: Letter
Times cited : (23)

References (5)
  • 1
    • 33947262990 scopus 로고    scopus 로고
    • Sorafenib in advanced renal cancer
    • McKeage K, Wagstaff AJ. Sorafenib in advanced renal cancer. Drugs 2007;67:475-83.
    • (2007) Drugs , vol.67 , pp. 475-483
    • McKeage, K.1    Wagstaff, A.J.2
  • 2
    • 33644533526 scopus 로고    scopus 로고
    • Imatinib mesylate as a cause of acute liver failure
    • Cross TJ, Bagot C, Portmann B et al. Imatinib mesylate as a cause of acute liver failure. Am J Hematol 2006;81:189-92.
    • (2006) Am J Hematol , vol.81 , pp. 189-192
    • Cross, T.J.1    Bagot, C.2    Portmann, B.3
  • 3
    • 33846545477 scopus 로고    scopus 로고
    • Acute drug induced hepatitis due to erlotinib. JOP
    • Ramanarayanan J, Scarpace SL. Acute drug induced hepatitis due to erlotinib. JOP 2007;8:39-43.
    • (2007) , vol.8 , pp. 39-43
    • Ramanarayanan, J.1    Scarpace, S.L.2
  • 4
    • 38749121331 scopus 로고    scopus 로고
    • Early imatinib-mesylate-induced hepatotoxicity in chronic myelogenous leukaemia
    • Kong JH, Yoo SH, Lee KE et al. Early imatinib-mesylate-induced hepatotoxicity in chronic myelogenous leukaemia. Acta Haematol 2007;118:205-8.
    • (2007) Acta Haematol , vol.118 , pp. 205-208
    • Kong, J.H.1    Yoo, S.H.2    Lee, K.E.3
  • 5
    • 0008348082 scopus 로고    scopus 로고
    • The European Medicines Agency, Scientific Discussion Nexavar®-H-C-690-II-05
    • The European Medicines Agency. European Public Assesment Report. Scientific Discussion Nexavar®-H-C-690-II-05.
    • European Public Assesment Report


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.